SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-23-160877
Filing Date
2023-06-06
Accepted
2023-06-05 17:48:57
Documents
2
Group Members
ARTAL GROUP S.A.ARTAL INTERNATIONAL MANAGEMENT S.A.ARTAL INTERNATIONAL S.C.A.INVUS ADVISORS, L.L.C.INVUS PUBLIC EQUITIES ADVISORS, LLCINVUS PUBLIC EQUITIES, L.P.INVUS US PARTNERS LLCMR. AMAURY WITTOUCKMR. RAYMOND DEBBANESTICHTING ADMINISTRATIEKANTOOR WEST

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d449914dsc13da.htm SC 13D/A 247077
2 EX-99.27 d449914dex9927.htm EX-99.27 29308
  Complete submission text file 0001193125-23-160877.txt   278620
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Subject) CIK: 0001062822 (see all company filings)

IRS No.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-60409 | Film No.: 23994108
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O THE INVUS GROUP, LLC 750 LEXINGTON AVENUE, 30TH FLOOR NEW YORK NY 10022
Business Address C/O THE INVUS GROUP, LLC 750 LEXINGTON AVENUE, 30TH FLOOR NEW YORK NY 10022 (212) 371-1717
Invus, L.P. (Filed by) CIK: 0001404570 (see all company filings)

IRS No.: 830359143
Type: SC 13D/A